Maria Koehler - Dec 10, 2021 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role: EVP, Chief Medical Officer
Signature: /s/ Steve Forte, Attorney-in-Fact
Stock symbol: RPTX
Transactions as of: Dec 10, 2021
Transactions value $: $100,048
Form type: 4
Date filed: 12/10/2021, 03:43 PM
Next filing: Dec 23, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPTX	Common Shares	Options Exercise	$99.9K	+48.5K	+92.31%	$2.06^*	101K	Dec 10, 2021	Direct
transaction	RPTX	Common Shares	Options Exercise	$124	+51	+0.05%	$2.43^*	101K	Dec 10, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RPTX	Employee Stock Option (right to buy)	Options Exercise	$0	-48.5K	-34.29%	$0.00	92.9K	Dec 10, 2021	Common Shares	48.5K	$2.06	Direct	F1
transaction	RPTX	Employee Stock Option (right to buy)	Options Exercise	$0	-51	-0.05%	$0.00	111K	Dec 10, 2021	Common Shares	51	$2.43	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Twenty-five percent (25%) of the shares subject to the option vested on May 1, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
F2	Twenty-five percent (25%) of the shares subject to the option vested on December 16, 2020, and one thirty-ninth (1/39th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.